Your Article Summary
See Latest ArticlesDifferent treatment outcomes with different formulations of clobetasol propionate 0.05% for the treatment of plaque psoriasis
Journal of Dermatological Treatment , 10/23/08
Mraz S et al. - The majority of adverse events for both products were mild in severity. Thus, while both of these formulations contain the same active ingredient at the same concentration, differences in their efficacy were observed when each treatment was used within its approved labeling guidelines.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Divalproex Sodium-Induced Eosinophilic Pleural Effusion
American Journal of Therapeutics, 12/04/09
Lithium and thyroid
Best Practice & Research Clinical Endocrinology & Metabolism, 12/04/09
Acute Generalized Exanthematous Pustulosis: A Rare Clinical Entity With Use of Piperacillin/Tazobactam
American Journal of Therapeutics, 12/04/09
Today in Dermatology...keeping you current
Receive free subspecialty "5-minute updates" via email
Acute Generalized Exanthematous Pustulosis: A Rare Clinical Entity With Use of Piperacillin/Tazobactam
American Journal of Therapeutics, 12/04/09
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/04/09
The Effect of Aminolevulinic Acid Photodynamic Therapy on Microcomedones and Macrocomedones
Dermatology, 12/04/09